Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma

被引:6
|
作者
Shi, Ke [1 ]
Hou, Jie [2 ]
Zhang, Qun [1 ]
Bi, Yufei [1 ]
Zeng, Xuanwei [1 ]
Wang, Xianbo [1 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Ctr Integrat Med, Beijing, Peoples R China
[2] Hengshui Hosp Tradit Chinese Med, Dept Spleen & Stomach Dis, Hengshui, Hebei, Peoples R China
来源
FRONTIERS IN NUTRITION | 2023年 / 10卷
关键词
hepatocellular carcinoma; dyslipidemia; high-density lipoprotein cholesterol; inflammation; prognosis; STAGE LIVER-DISEASE; MELD SCORE; MODEL; METABOLISM; HDL; INFLAMMATION; HEPATECTOMY; PROGNOSIS; SEPSIS;
D O I
10.3389/fnut.2023.1127913
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundInflammatory responses and lipid metabolism disorders contribute to the development and prognosis of hepatocellular carcinoma (HCC). This study aimed to investigate the prognostic value of lipid-related inflammatory parameters in patients with HCC. MethodsFrom January 2010 to June 2017, we enrolled 1,639 patients with HCC at Beijing Ditan Hospital. Multivariate Cox regression analysis and area under the receiver operating characteristic (AUC) analysis were used to evaluate and compare the predictability and reliability of high-density lipoprotein cholesterol (HDL-C), neutrophil-to-HDL-C ratio (NHR), monocyte-to-HDL-C ratio (MHR), and lymphocyte-to-HDL-C ratio (LHR) values. A restricted cubic spline was used to explore the association between the NHR and 3-year mortality in patients with HCC. Differences in survival rates were estimated using the Kaplan-Meier method and compared using the log-rank test. The results were validated in an internal cohort between July 2017 and October 2019 (n = 373). ResultsAfter adjusting for confounding variables, NHR was independently associated with 3-year mortality, both as a continuous and categorical variable (both p < 0.05). The correlation between the mortality and the MHR and LHR was not statistically significant. The NHR showed a suitable prognostic value (AUC at 3 years: 0.740), similar to that of the Model for End-stage Liver Disease (MELD) (AUC at 3 years: 0.761). In the validation cohort, the AUC of the NHR was 0.734 at 3 years. The optimal cut-off values of NHR and MELD were 3.5 and 9, respectively. The 3-year survival rates in the low- (NHR < 3.5 and MELD <9) and high-risk (NHR >= 3.5 and MELD >= 9) groups were 81.8 and 19.4%, respectively, in the training cohort, and 84.6 and 27.5%, respectively, in the validation cohort. ConclusionBaseline NHR is a promising prognostic parameter for mortality in patients with HCC and patients with NHR >= 3.5 and MELD >= 9 have a high mortality rate.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] PROGNOSTIC VALUE OF THE MONOCYTE/HIGH DENSITY LIPOPROTEIN CHOLESTEROL RATIO IN DIABETIC NEPHROPATHY PATIENTS
    Kahraman, Cuneyt
    Kahraman, Nilufer Kuzeyli
    Cosgun, Suleyman
    [J]. ACTA MEDICA MEDITERRANEA, 2016, 32 (04): : 981 - 985
  • [42] Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects
    Zhu, Chen
    Wu, Juan
    Wu, Yixian
    Guo, Wen
    Lu, Jing
    Zhu, Wenfang
    Li, Xiaona
    Xu, Nianzhen
    Zhang, Qun
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [43] Neutrophil-lymphocyte ratio is associated with low high-density lipoprotein cholesterol in healthy young men
    Tok, Duran
    Iscen, Sinan
    Ozenc, Salim
    [J]. SAGE OPEN MEDICINE, 2014, 2
  • [44] Neutrophil to high-density lipoprotein cholesterol ratio, a novel risk factor associated with acute ischemic stroke
    Yu, Lina
    Ma, Ke
    Hao, Jian
    Zhang, Bin
    [J]. MEDICINE, 2023, 102 (26) : E34173
  • [45] Association between the variability of non-high-density lipoprotein cholesterol and the neutrophil-to-lymphocyte ratio in patients with coronary heart disease
    Chen, Yifan
    Zhang, Sisi
    Tao, Yecheng
    Hu, Wenyi
    Li, Duanbin
    Shen, Xiaohua
    Li, Ya
    Lin, Maoning
    Zhang, Wenbin
    Liu, Xianglan
    Xie, Daqi
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [46] Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
    Sheng, Guotai
    Liu, Dingyang
    Kuang, Maobin
    Zhong, Yanjia
    Zhang, Shuhua
    Zou, Yang
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1677 - 1686
  • [47] Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
    Moradi, Hamid
    Streja, Elani
    Kashyap, Moti L.
    Vaziri, Nosratola D.
    Fonarow, Gregg C.
    Kalantar-Zadeh, Kamyar
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (08) : 1554 - 1562
  • [48] The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of osteoporosis among US adults: analysis of NHANES data
    Wang, Jinzhou
    Li, Shanshan
    Pu, Hongyu
    He, Jiangtao
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [49] High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among US Veterans
    Bowe, Benjamin
    Xie, Yan
    Xian, Hong
    Balasubramanian, Sumitra
    Zayed, Mohamed A.
    Al-Aly, Ziyad
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (10): : 1784 - 1793
  • [50] Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy
    Oka, Ryo
    Utsumi, Takanobu
    Endo, Takumi
    Yano, Masashi
    Kamijima, Shuichi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (06) : 634 - +